載入...
Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer
BACKGROUND: Less evidence is known about the role of early changes in serum biomarker after androgen deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). Here we evaluated the impact of pre-treatment prognostic factors and early changes in serum biomarkers...
Na minha lista:
| 發表在: | BMC Urol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5941329/ https://ncbi.nlm.nih.gov/pubmed/29739368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-018-0353-4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|